Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients?

Pyne, Nigel J. and Pyne, Susan (2018) Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients? Frontiers in Oncology, 8 (417). pp. 1-3. ISSN 2234-943X

[img]
Preview
 Text (Pyne-Pyne-FiO2018-Does-the-sphingosine-1-phosphate-receptor-1-provide-a-better)
Pyne_Pyne_FiO2018_Does_the_sphingosine_1_phosphate_receptor_1_provide_a_better.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (101kB)| Preview

    Abstract

    Recently, Lei et al., (2018) published an article in Cancer Medicine claiming a survival benefit of sphingosine 1-phosphate (S1P) and sphingosine 1-phosphate receptor 1 (S1P1) expression in breast cancer patients. This controversial study opposes the prevailing view concerning the deleterious role of S1P in cancer. This is discussed in depth in the current opinion article.

    Creators(s): Pyne, Nigel J. ORCID logoORCID: https://orcid.org/0000-0002-5657-4578 and Pyne, Susan ORCID logoORCID: https://orcid.org/0000-0002-6608-9584;
    Item type:Article
    ID code:65555
    Keywords:sphingosine 1-phosphate, Sphingosine 1-phosphate receptor 1, breast cancer, migration, growth, Neoplasms. Tumors. Oncology (including Cancer), Oncology
    Subjects:Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
    Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
    Depositing user: Pure Administrator
    Date deposited:27 Sep 2018 13:18
    Last modified:21 Jan 2021 10:26
    Related URLs:
    URI:https://strathprints.strath.ac.uk/id/eprint/65555
    Export data:
    CORE (COnnecting REpositories)